3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Neoplasm Metastasis
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Neuroendocrine
1
Anophthalmia with pulmonary hypoplasia
1
Interventions
Bevacizumab
32
Cetuximab
28
Fluorouracil
26
Leucovorin
24
Specimen Handling
23
Oxaliplatin
23
pembrolizumab
18
Biopsy
16
Magnetic Resonance Spectroscopy
14
Irinotecan
13
Nivolumab
9
atezolizumab
7
Folfox protocol
7
fludarabine
6
balstilimab
6
Pemetrexed
6
Panitumumab
6
Cyclophosphamide
6
Cisplatin
6
Carboplatin
6
Capecitabine
6
trifluridine tipiracil drug combination
5
encorafenib
5
Standard of Care
5
IFL protocol
5
HMPL-013
5
Gemcitabine
5
dehydroftorafur
4
Immunoglobulin G
4
Disulfides
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
budigalimab
×
30 days
×
Clear all
No trials found.